PUK10 Cost-Effectiveness Analysis of Solifenacin Versus Oxybutynin Immediate-Release in the Treatment of Patients with Overactive Bladder in the United Kingdom
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.545
https://www.valueinhealthjournal.com/article/S1098-3015(11)02107-3/fulltext
Title :
PUK10 Cost-Effectiveness Analysis of Solifenacin Versus Oxybutynin Immediate-Release in the Treatment of Patients with Overactive Bladder in the United Kingdom
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02107-3&doi=10.1016/j.jval.2011.08.545
First page :
A332
Section Title :
Urinary/Kidney Disorders
Open access? :
No
Section Order :
517